Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8992)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 8, 2015 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ashtari S, Pourhoseingholi MA, Zali MR. Non-alcohol fatty liver disease in Asia: Prevention and planning. World J Hepatol 2015; 7(13): 1788-1796 [PMID: 26167252 DOI: 10.4254/wjh.v7.i13.1788] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i13/1788.htm |
| Number | Citing Articles |
| 1 |
Helda Tutunchi, Maryam Saghafi-Asl, Mohammad Asghari-Jafarabadi, Alireza Ostadrahimi. The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults. BMC Research Notes 2020; 13(1) doi: 10.1186/s13104-020-05059-5
|
| 2 |
Zhe Jiang, Yuki Kimura, Bungo Shirouchi, Yasutake Tanaka, Wei-ting Tsai, Xingyu Yuan, Masao Sato. Dietary egg white protein hydrolysate improves orotic acid-induced fatty liver in rats by promoting hepatic phospholipid synthesis and microsomal triglyceride transfer protein expression. The Journal of Nutritional Biochemistry 2021; 98: 108820 doi: 10.1016/j.jnutbio.2021.108820
|
| 3 |
Bunchai Chongmelaxme, Pochamana Phisalprapa, Ratree Sawangjit, Piyameth Dilokthornsakul, Nathorn Chaiyakunapruk. Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand. PharmacoEconomics 2019; 37(2): 267 doi: 10.1007/s40273-018-0736-0
|
| 4 |
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Giorgia Litrico, Marcello Agosta, Gaetano La Greca, Saverio Latteri. Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-50190-5
|
| 5 |
Yu-Jin Kwon, Ji-Hye Kim, Dong-Hyuk Jung. Association Between Nonalcoholic Fatty Liver Disease and Intraocular Pressure in Korean Adults. Journal of Glaucoma 2018; 27(12): 1099 doi: 10.1097/IJG.0000000000001036
|
| 6 |
Ayşe Pınar TUNÇER, Altuğ KÜÇÜKGÜL, Mehmet Mustafa İŞGÖR. İn Vitro Lipopolisakkarit Uyarımlı Karaciğer Yangı Modelinde Alfa-Terpineol’ün Etkinliğinin Araştırılması. Etlik Veteriner Mikrobiyoloji Dergisi 2022; 33(1): 71 doi: 10.35864/evmd.1053710
|
| 7 |
Tingting Shi, Li Wu, Wenjun Ma, Liping Ju, Minghui Bai, Xiaowei Chen, Shourong Liu, Xingxin Yang, Junping Shi. Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/8749564
|
| 8 |
Neda Azizi, Mohammad Reza Amini, Kurosh Djafarian, Sakineh Shab-Bidar. The Effects of Nigella sativa Supplementation on Liver Enzymes Levels: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Nutrition Research 2021; 10(1): 72 doi: 10.7762/cnr.2021.10.1.72
|
| 9 |
Mazhar Hussain, Muhammad Zafar Majeed Babar, Saba Tariq, Muhammad Irfan Ahmad, Lubna Akhtar. Therapeutic outcome of dapagliflozin on various parameters in non-alcoholic fatty liver disease (NAFLD) patients. International Journal of Diabetes in Developing Countries 2022; 42(2): 290 doi: 10.1007/s13410-021-00980-2
|
| 10 |
Hepatoprotective effects of red beetroot‐based beverages against CCl4‐induced hepatic stress inSprague Dawleyrats. Journal of Food Biochemistry 2019; 43(12) doi: 10.1111/jfbc.13057
|
| 11 |
M. A. Osadchuk, E. D. Mironova. Non-viral liver diseases: pathogenetic approaches to therapy. Medical alphabet 2019; 3(20): 30 doi: 10.33667/2078-5631-2019-2-20(395)-30-36
|
| 12 |
Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. Comprehensive Gut Microbiota. 2022; : 475 doi: 10.1016/B978-0-12-819265-8.00079-6
|
| 13 |
Junbin Yan, Yunmeng Nie, Yuan Liu, Jingya Li, Liyan Wu, Zhiyun Chen, Beihui He. Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.824597
|
| 14 |
Ju-Hsin Cheng, Ho-Cheng Wu, Chia-Hung Yen, Tsong-Long Hwang, Horng-Huey Ko, Hsun-Shuo Chang. Chemical Constituents with Anti-Lipid Droplet Accumulation and Anti-Inflammatory Activity from Elaeagnus glabra. Plants 2023; 12(16): 2943 doi: 10.3390/plants12162943
|
| 15 |
Yun-zi Liu, Wei Peng, Ji-kuai Chen, Wen-jun Su, Wen-jie Yan, Yun-xia Wang, Chun-lei Jiang. FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice. PeerJ 2019; 7: e7668 doi: 10.7717/peerj.7668
|
| 16 |
Ayse L. Mindikoglu, Antone R. Opekun, Sood K. Gagan, Sridevi Devaraj. Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/3932491
|
| 17 |
Nima Motamed, Masoudreza Sohrabi, Hossein Ajdarkosh, Gholamreza Hemmasi, Mansooreh Maadi, Fatemeh Sima Sayeedian, Reza Pirzad, Khadijeh Abedi, Sivil Aghapour, Mojtaba Fallahnezhad, Farhad Zamani. Fatty liver index <i>vs</i> waist circumference for predicting non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(10): 3023-3030 doi: 10.3748/wjg.v22.i10.3023
|
| 18 |
Suresh Bendwal, Kavita Bendwal, Dhawale R.G. PREVALENCE OF NAFLD IN TYPE 2 DIABETES MELLITUS AND ITS CORRELATION WITH HBA1C LEVEL. Journal of Evidence Based Medicine and Healthcare 2017; 4(31): 1845 doi: 10.18410/jebmh/2017/360
|
| 19 |
Anup Kumar, Namdev More, Ashish Sharma, Dhanajay Jawade, Gournag Hari Gupta, Aishwarya Balu, Govinda Kapusetti. Ultrahigh Sensitive Graphene Oxide/Conducting Polymer Composite Based Biosensor for Cholesterol and Bilirubin Detection. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4182086
|
| 20 |
Chang-Xi Chen, Yu-Shan Mao, Parker Foster, Zhong-Wei Zhu, Juan Du, Chuan-Yong Guo. Possible association between Helicobacter pylori infection and nonalcoholic fatty liver disease. Applied Physiology, Nutrition, and Metabolism 2017; 42(3): 295 doi: 10.1139/apnm-2016-0499
|
| 21 |
Mohammad Taghi Hatami, Elham Eftekhari. The Effect of Combined Aerobic and Resistance Training on Hepatic Enzymes in Males With Nonalcoholic Fatty Liver. Biotechnology and Health Sciences 2016; 3(3) doi: 10.17795/bhs-36162
|
| 22 |
Zobair M. Younossi, Linda Henry, Haley Bush, Alita Mishra. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2018; 22(1): 1 doi: 10.1016/j.cld.2017.08.001
|
| 23 |
Saeed Hamid, Amna Subhan Butt, Fatima Sharif, Zishan Haider, Mohammad Salih, Safia Awan, Aatif A Khan, Jaweed Akhter. Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors. Euroasian Journal of Hepato-Gastroenterology 2019; 9(1): 9 doi: 10.5005/jp-journals-10018-1288
|
| 24 |
Manar N. Amin, Muhammad A. Rushdi, Raghda N. Marzaban, Ayman Yosry, Kang Kim, Ahmed M. Mahmoud. Wavelet-based computationally-efficient computer-aided characterization of liver steatosis using conventional B-mode ultrasound images. Biomedical Signal Processing and Control 2019; 52: 84 doi: 10.1016/j.bspc.2019.03.010
|
| 25 |
Alireza Naderi, Mojtaba Farjam, Maryam Mojarrad Sani, Ashkan Abdollahi, Abdulhakim Alkamel, Omid Keshavarzian, Reza Tabrizi. The association between nonalcoholic fatty liver disease and corrected QT interval prolongation among generally healthy Iranian population: Fasa Cohort Study (FACS). Clinical Cardiology 2023; 46(6): 615 doi: 10.1002/clc.24015
|
| 26 |
Jie Li, Biyao Zou, Yee Hui Yeo, Yuemin Feng, Xiaoyu Xie, Dong Hyun Lee, Hideki Fujii, Yuankai Wu, Leslie Y Kam, Fanpu Ji, Xiaohe Li, Nicholas Chien, Mike Wei, Eiichi Ogawa, Changqing Zhao, Xia Wu, Christopher D Stave, Linda Henry, Scott Barnett, Hirokazu Takahashi, Norihiro Furusyo, Yuichiro Eguchi, Yao-Chun Hsu, Teng-Yu Lee, Wanhua Ren, Chengyong Qin, Dae Won Jun, Hidenori Toyoda, Vincent Wai-Sun Wong, Ramsey Cheung, Qiang Zhu, Mindie H Nguyen. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2019; 4(5): 389 doi: 10.1016/S2468-1253(19)30039-1
|
| 27 |
Hua Zhu, Zhenjiong Wang, Yulong Wu, Haitao Jiang, Feng Zhou, Xiaohong Xie, Renlei Wang, Chun Hua. Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease. International Journal of Biological Macromolecules 2019; 128: 363 doi: 10.1016/j.ijbiomac.2019.01.141
|
| 28 |
Chyntia Olivia Maurine JASIRWAN, Cosmas Rinaldi Adithya LESMANA, Irsan HASAN, Andri Sanityosos SULAIMAN, Rino Alvani GANI. The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. Bioscience of Microbiota, Food and Health 2019; 38(3): 81 doi: 10.12938/bmfh.18-032
|
| 29 |
Sulev Reisberg, Nicholas Galwey, Paul Avillach, Anna‐Stina Sahlqvist, Liis Kolberg, Reedik Mägi, Tõnu Esko, Jaak Vilo, Glen James. Comparison of variation in frequency for SNPs associated with asthma or liver disease between Estonia, HapMap populations and the 1000 genome project populations. International Journal of Immunogenetics 2019; 46(2): 49 doi: 10.1111/iji.12413
|
| 30 |
Behnam Honarvar, Kamran Bagheri Lankarani, Parisa Keshani, Tayebe Rafiee. Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran. Hepatitis Monthly 2017; 17(4) doi: 10.5812/hepatmon.44962
|
| 31 |
E.L. LeCluyse, L.M. Norona, J.A. Akingbasote, L.S. Howell, J.L. Woodhead, M.J. Cross, A.B. Roth, C.E. Goldring. Comprehensive Toxicology. 2018; : 651 doi: 10.1016/B978-0-12-801238-3.64267-8
|
| 32 |
Shahinul Alam, Thupten Kelsang Lama, Golam Mustafa, Mahabubul Alam, Nooruddin Ahmad. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018; doi: 10.5772/intechopen.71159
|
| 33 |
Roya Mansour-Ghanaei, Fariborz Mansour-Ghanaei, Mohammadreza Naghipour, Farahnaz Joukar, Zahra Atrkar-Roushan, Mohammadjavad Tabatabaii, Najmeh Ghorani. The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS). Journal of Medicine and Life 2018; 11(3): 194 doi: 10.25122/jml-2018-0031
|
| 34 |
Ornuma Haonon, Zhigang Liu, Rungtiwa Dangtakot, Porntip Pinlaor, Anucha Puapairoj, Ubon Cha'on, Kitti Intuyod, Thatsanapong Pongking, Chanakan Jantawong, Chatchawan Sengthong, Apisit Chaidee, Sudarat Onsurathum, Jia V. Li, Somchai Pinlaor. Opisthorchis viverrini infection induces metabolic disturbances in hamsters fed with high fat/high fructose diets: Implications for liver and kidney pathologies. The Journal of Nutritional Biochemistry 2022; 107: 109053 doi: 10.1016/j.jnutbio.2022.109053
|
| 35 |
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi-Asl, Mohammad-Javad Hosseinzadeh-Attar, Abolhasan Shakeri, Mohammad Asghari-Jafarabadi, Neda Roshanravan, Nazila Farrin, Mohammad Naemi, Milad Hasankhani. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes. Pharmacological Research 2020; 156: 104770 doi: 10.1016/j.phrs.2020.104770
|
| 36 |
Jiayuan Zhang, Xiaoling Zang, Jinxiao Lv, Yicong Zhang, Zhihua Lv, Mingming Yu. Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment. International Journal of Molecular Sciences 2023; 24(2): 1502 doi: 10.3390/ijms24021502
|
| 37 |
Anoop Tiwari, Surendra G, Soumya Meka, Bincy Varghese, Gayatri Vishwakarma, Ramu Adela. The effect of Nigella sativa on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Human Nutrition & Metabolism 2022; 28: 200146 doi: 10.1016/j.hnm.2022.200146
|
| 38 |
Sheng-xi Meng, Qian Liu, Ya-jun Tang, Wen-jing Wang, Qing-shan Zheng, Hua-jie Tian, Dong-sheng Yao, Lin Liu, Jing-hua Peng, Yu Zhao, Yi-yang Hu, Qin Feng. A Recipe Composed of Chinese Herbal Active Components Regulates Hepatic Lipid Metabolism of NAFLDIn VivoandIn Vitro. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/1026852
|
| 39 |
Ladan Aghakhani, Neda Haghighat, Masoud Amini, Seyed Vahid Hosseini, Seyed Jalil Masoumi, Fariborz Mansour-Ghanaei. The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/5980390
|
| 40 |
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iranian Biomedical Journal 2022; 26(4): 252 doi: 10.52547/ibj.3647
|
| 41 |
Anup Kumar, Gourang Hari Gupta, Gajendar Singh, Namdev More, Keerthana M, Ashish Sharma, Dhanajay Jawade, Aishwarya Balu, Govinda Kapusetti. Ultrahigh sensitive graphene oxide/conducting polymer composite based biosensor for cholesterol and bilirubin detection. Biosensors and Bioelectronics: X 2023; 13: 100290 doi: 10.1016/j.biosx.2022.100290
|
| 42 |
Ankit Sharma, Kunal Malhotra, Ashok Kumar Kaundal, Anil Malhotra. Prevalence of Non-Alcoholic Fatty Liver with Gall Stones Disease in Himalayan Population. Journal of Evolution of Medical and Dental Sciences 2020; 9(12): 932 doi: 10.14260/jemds/2020/201
|
| 43 |
Donna L. White, Fasiha Kanwal, Li Jiao, Hashem B. El-Serag. Hepatocellular Carcinoma. 2016; : 3 doi: 10.1007/978-3-319-34214-6_1
|
| 44 |
Xin Su, Yi Kong, Daoquan Peng. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease. Clinica Chimica Acta 2019; 498: 30 doi: 10.1016/j.cca.2019.08.005
|
| 45 |
Farhad Vahid, Nitin Shivappa, Azita Hekmatdoost, James R Hebert, Hossein Poustchi, Ali Shamsipour, Tannaz Eslamparast, Mohammad Meibodi, Diyako Rahmani. Association of Pro-inflammatory Dietary Intake and Non-Alcoholic Fatty Liver Disease: Findings from Iranian case-control study. International Journal for Vitamin and Nutrition Research 2018; 88(3-4): 144 doi: 10.1024/0300-9831/a000571
|
| 46 |
Tran Thi Khanh Tuong, Dang Khoa Tran, Pham Quang Thien Phu, Tong Nguyen Diem Hong, Thien Chu Dinh, Dinh Toi Chu. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan. Diagnostics 2020; 10(3): 159 doi: 10.3390/diagnostics10030159
|
| 47 |
Zahra Keshavarz, Mehran Rahimlou, Mojtaba Farjam, Reza Homayounfar, Mahmoud Khodadost, Ashkan Abdollahi, Reza Tabrizi. Non-alcoholic fatty liver disease and dairy products consumption: Results from FASA Persian cohort study. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.962834
|
| 48 |
Yi Wu, Yu Wu, I-Fen Chen, Yi-Lung Wu, Chin Chuang, Han Huang, Shyh Kuo. Reparative Effects of Astaxanthin-Hyaluronan Nanoaggregates against Retrorsine-CCl4-Induced Liver Fibrosis and Necrosis. Molecules 2018; 23(4): 726 doi: 10.3390/molecules23040726
|